Nitric oxide production with preeclampsia

被引:63
作者
Ranta, V
Viinikka, L
Halmesmäki, E
Ylikorkala, O
机构
[1] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Clin Chem, FIN-00290 Helsinki, Finland
关键词
D O I
10.1016/S0029-7844(98)00465-7
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To clarify production of nitric oxide with preeclampsia. Methods: Production of nitric oxide and elimination of its metabolites, nitrite and nitrate, determines ultimately the level of those metabolites in plasma of subjects whose diets lack them. We measured simultaneously plasma levels and renal clearance of nitrite and nitrate in 20 women with preeclampsia and in 21 healthy pregnant women. Fifteen preeclamptic gravidas were receiving antihypertensive medication and five received betamethasone 1-4 days before the study. Subjects were prescribed low nitrite and nitrate diets for 24 hours and fasted overnight before collection of plasma and urine samples. Nitrite and nitrate were measured spectrophotometrically by Griess reaction. Results: Preeclamptic women had significantly higher plasma levels of nitrite and nitrate (18.1 +/- 6.2 mu mol/L versus 13.0 +/- 4.3 mu mol/L, mean +/- standard deviation [SD], P= .009), which because renal clearance did not differ (0.6 +/- 0.3 versus 0.7 +/- 0.3 mL/s), indicated increased production of nitric oxide with preeclampsia that was unaffected by antihypertensives or betamethasone. The mean plasma level of endothelin-l was increased (5.1 +/- 1.4 versus 3.6 +/- 1.0 pg/mL, P <.001), and urinary output of the prostacyclin metabolite 2,3-dinor-6-keto-prostaglandin F-1 alpha was decreased (39.1 +/- 18.0 versus 61.3 +/- 35.6 ng/mmol creatinine, P = .019) with preeclampsia. These two endothelial markers showed no relation to plasma nitrite and nitrate. Conclusion: Nitric oxide production was increased with preeclampsia. The biologic significance of increased production is unknown, but it might be compensation for the vasoconstriction of preeclampsia. (C) 1999 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:442 / 445
页数:4
相关论文
共 19 条
[1]
RELATIONSHIP BETWEEN NITRIC-OXIDE SYNTHESIS AND INCREASE IN SYSTOLIC BLOOD-PRESSURE IN WOMEN WITH HYPERTENSION IN PREGNANCY [J].
CAMERON, IT ;
VANPAPENDORP, CL ;
PALMER, RMJ ;
SMITH, SK ;
MONCADA, S .
HYPERTENSION IN PREGNANCY, 1993, 12 (01) :85-92
[2]
PLASMA ENDOTHELIN LEVELS IN PREECLAMPSIA - ELEVATION AND CORRELATION WITH URIC-ACID LEVELS AND RENAL IMPAIRMENT [J].
CLARK, BA ;
HALVORSON, L ;
SACHS, B ;
EPSTEIN, FH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (03) :962-968
[3]
Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia [J].
Davidge, ST ;
Stranko, CP ;
Roberts, JM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (03) :1008-1013
[4]
EVANS TG, 1994, CLIN EXP IMMUNOL, V97, P83
[5]
ANALYSIS OF NITRATE, NITRITE, AND [N-15]-LABELED NITRATE IN BIOLOGICAL-FLUIDS [J].
GREEN, LC ;
WAGNER, DA ;
GLOGOWSKI, J ;
SKIPPER, PL ;
WISHNOK, JS ;
TANNENBAUM, SR .
ANALYTICAL BIOCHEMISTRY, 1982, 126 (01) :131-138
[6]
Cyclic guanosine 3',5' monophosphate concentrations in pre-eclampsia: Effects of hydralazine [J].
LopezJaramillo, P ;
Narvaez, M ;
Calle, A ;
Rivera, J ;
Jacome, P ;
Ruano, C ;
Nava, E .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (01) :33-38
[7]
MONCADA S, 1991, PHARMACOL REV, V43, P109
[8]
Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension [J].
Nobunaga, T ;
Tokugawa, Y ;
Hashimoto, K ;
Kimura, T ;
Matsuzaki, N ;
Nitta, Y ;
Fujita, T ;
Kidoguchi, K ;
Azuma, C ;
Saji, F .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1996, 41 (03) :189-193
[9]
The calcium-dependent nitric oxide production of human vascular endothelial cells in preeclampsia [J].
Orpana, AK ;
Avela, K ;
Ranta, V ;
Viinikka, L ;
Ylikorkala, O .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (03) :1056-1060
[10]
THE ROLE OF NITRIC-OXIDE IN ENDOTHELIAL-CELL DAMAGE AND ITS INHIBITION BY GLUCOCORTICOIDS [J].
PALMER, RMJ ;
BRIDGE, L ;
FOXWELL, NA ;
MONCADA, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (01) :11-12